What is oral mucositis (stomatitis) in chemotherapy? Oral health 12. 01. 2022 “I have cancer and receive chemotherapy. I have stomatitis, my mouth is painful, I cannot eat”. Professor Ourania Nicolatou-Galitis, oral oncologist and Dr Nikolaos Tsoukalas, medical oncologist were honored to serve editing the section of Oral Mucositis in Cancer as the Best Practice educational module for Oncologists. Drs Tsoukalas and Nicolatou-Galitis would like to gratefully acknowledge Dr Eleni Arvanitou, who contributed to the updating of this topic, and Dr Rajesh V. Lalla, a previous contributor. Oral mucositis secondary to cancer therapy is an acute inflammation of the oral mucosa in response to systemic oncology therapy and/or radiation to fields involving the oral cavity. The clinical presentation ranges from a general erythematous oral mucosa to ulceration. Lesions are often very painful, may compromise nutrition and oral hygiene, and can increase the risk of local and systemic infection. Furthermore, severe oral mucositis may necessitate an undesirable dose-reduction and/or a break in cancer therapy. Therefore, mucositis is a highly significant complication of cancer therapy, with a potential impact on patient prognosis. The authors, Drs Nikolaos Tsoukalas, Nicolatou-Galitis and Eleni Arvanitou are pleased to invite you to visit the website of BMJ Best Practice for Oral Mucositis and read all this important issue in cancer therapy. Tags: chemotherapy , stomatitis , radiotherapy , wound , cancer
Conference of the Hellenic Society of Head and Neck Cancer Events, Seminars, & Publications 18. 11. 2025 The Conference of the Hellenic Society of Head and Neck Cancer took place on 7–8 November 2025 at LAED in Athens with outstanding success, high participation, and a rich scientific program.The high q...[Read more]
Medication-Related Osteonecrosis of the Jaw (MRONJ): From Theory to Practice – Advanced Training Webinar Events, Seminars, & Publications 28. 01. 2026 The Next Step in Managing Patients on Antiresorptive MedicationsOn January 16, 180 dentists attended our first webinar on MRONJ and risk assessment.The response was immediate:“The STEPS and their eval...[Read more]
The 3-Step Safety System for Medication-Related Osteonecrosis of the Jaw (MRONJ) Events, Seminars, & Publications 07. 01. 2026 How to confidently treat patients receiving antiresorptive medicationsConnect with:Internationally Awarded Professor Ourania Nicolatou-Galitis,Member of the European Expert Panel on Osteonecrosis(Medi...[Read more]